The Children’s Tumor Foundation (CTF), in collaboration with CureNFwithJack (CNFWJ), is proud to announce the next phase of an innovative biomarker project aimed at revolutionizing the detection and monitoring of cancerous tumors in patients with NF1. Building on earlier groundbreaking research funded by CTF, this non-invasive approach holds tremendous promise for revolutionizing cancer detection. For NF1 patients, it offers life-changing benefits, including the potential for earlier detection, less invasive monitoring, and improved outcomes. By identifying cancer before symptoms arise, this approach enables proactive intervention. It reduces the need for surgeries and frequent imaging scans, making monitoring less burdensome. Most importantly, it paves the way for personalized treatment plans and allows for earlier action when tumors show signs of becoming cancerous. |